{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:46:25Z","timestamp":1790232385820,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cpcardiol.2021.100799","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T09:57:31Z","timestamp":1611482251000},"page":"100799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease"],"prefix":"10.1016","volume":"46","author":[{"given":"David A.","family":"Bulger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheharyar","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Aziz","family":"Asbeutah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif","family":"Kayali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid A.K.","family":"Shirwany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Paul","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami N.","family":"Khouzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2021.100799_bib0001","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2105\/AJPH.83.9.1289","article-title":"CDC WONDER: A comprehensive on-line public health information system of the Centers for Disease Control and Prevention","volume":"83","author":"Friede","year":"1993","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0002","series-title":"Nouveau trait\u00e9 de vapeurs, ou Trait\u00e9 de maladies des nerfs dans lequel on d\u00e9veloppe les vrais principes des vapeurs","author":"Pressavin","year":"1770"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0003","first-page":"e596","article-title":"ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0004","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archderm.141.12.1537","article-title":"Prevalence and treatment of psoriasis in the United Kingdom: a population-based study","volume":"141","author":"Gelfand","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0006","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0007","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jid.2017.07.841","article-title":"Objective measures of psoriasis severity\u00a0predict mortality: a prospective population-based cohort study","volume":"138","author":"Noe","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0008","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2017.10.050","article-title":"Psoriasis and the risk of diabetes: a prospective population-based cohort study","volume":"78","author":"Wan","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0009","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task\u00a0Force\u00a0on\u00a0Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1978.tb02012.x","article-title":"Psoriasis and occlusive vascular disease","volume":"99","author":"McDonald","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","article-title":"Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients","volume":"19","author":"Mallbris","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0012","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000182256","article-title":"Chronic plaque psoriasis is associated with increased arterial stiffness","volume":"218","author":"Gisondi","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0013","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamadermatol.2014.2094","article-title":"Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom","volume":"151","author":"Takeshita","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0014","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/art.38227","article-title":"Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.atherosclerosis.2014.11.004","article-title":"Association between psoriasis and coronary calcium score","volume":"237","author":"Staniak","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0017","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","article-title":"Comparison of coronary artery calcium scores between patients with psoriasis and type 2 diabetes","volume":"152","author":"Mansouri","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0018","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/cvr\/cvz009","article-title":"Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study","volume":"115","author":"Elnabawi","year":"2019","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0019","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.CIR.94.5.1175","article-title":"Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group","volume":"94","author":"Wexler","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","article-title":"Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study","volume":"136","author":"Lerman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0021","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/ehy128","article-title":"Interleukin-1 blockade in cardiovascular diseases: a clinical update","volume":"39","author":"Buckley","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0022","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fimmu.2019.00892","article-title":"An integrated approach to unravel hidradenitis suppurativa etiopathogenesis","volume":"10","author":"Tricarico","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0023","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/postgradmedj-2013-131994","article-title":"Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease","volume":"90","author":"Dufour","year":"2014","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0024","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0026","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2133.1990.tb06264.x","article-title":"Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands","volume":"122","author":"Yu","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0027","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0028","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/exd.12142","article-title":"Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne","volume":"22","author":"Melnik","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0029","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0031","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0032","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0033","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/bjd.15778","article-title":"Hidradenitis suppurativa and electrocardiographic changes: a cross-sectional population study","volume":"178","author":"Juhl","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0034","first-page":"289","article-title":"Hidradenitis suppurativa is associated with higher heart rate but not atrial fibrillation: a comparative cross-sectional study of 462 individuals with hidradenitis suppurativa in Denmark","volume":"26","author":"Miller","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190568","article-title":"Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa","volume":"13","author":"Gonz\u00e1lez-L\u00f3pez","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0036","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/bjd.15776","article-title":"European Heart Systemic Coronary Risk Evaluation may underestimate cardiovascular risk after assessing cardiovascular disease with carotid ultrasound in hidradenitis suppurativa","volume":"178","author":"Gonz\u00e1lez","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","article-title":"Cardiac manifestations of systemic lupus erythematosus","volume":"40","author":"Miner","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0038","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1573397113666170704102444","article-title":"Cardiovascular and pulmonary manifestations of systemic lupus erythematosus","volume":"13","author":"Tselios","year":"2017","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0039","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","article-title":"Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies","volume":"124","author":"Zuily","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","article-title":"Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution","volume":"120","author":"Moyssakis","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0041","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjms.2017.07.007","article-title":"Antiphospholipid antibodies and heart valve disease in systemic lupus erythematosus","volume":"355","author":"Ruiz","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0042","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/kem371","article-title":"Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]","volume":"47","author":"Apte","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0043","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/acr.22589","article-title":"Treatment algorithms in systemic lupus erythematosus","volume":"67","author":"Muangchan","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0044","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","article-title":"The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review","volume":"43","author":"Schoenfeld","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2249.1997.d01-948.x","article-title":"Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages","volume":"107","author":"Hasunuma","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0046","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0047","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10067-017-3582-0","article-title":"Prevalence of resting-ECG abnormalities in systemic lupus erythematosus: a single-center experience","volume":"36","author":"Myung","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(94)70128-8","article-title":"Acanthosis nigricans","volume":"31","author":"Schwartz","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D36FJ340W2","article-title":"Acanthosis nigricans in obese patients: Presentations and implications for prevention of atherosclerotic vascular disease","volume":"6","author":"Katz","year":"2000","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/2229-5178.137765","article-title":"An approach to acanthosis nigricans","volume":"5","author":"Phiske","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0051","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2337\/diacare.25.6.1009","article-title":"Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study","volume":"25","author":"Stoddart","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0052","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1525-1470.2007.00547.x","article-title":"Acanthosis nigricans: a common finding in overweight youth","volume":"24","author":"Brickman","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0053","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1365-2133.2002.05150.x","article-title":"Genes, growth factors and acanthosis nigricans","volume":"147","author":"Torley","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0054","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01213299","article-title":"Transforming growth factor-alpha (TGF \u03b1)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF \u03b1 in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus","volume":"32","author":"Koyama","year":"1997","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0055","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.3747\/co.19.997","article-title":"Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast dcis: case and review","volume":"19","author":"Jakubovic","year":"2012","journal-title":"Curr Oncol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0056","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/1984-0462\/;2018;36;3;00017","article-title":"Association between acanthosis nigricans and other cardiometabolic risk factors in children and adolescents with overweight and obesity","volume":"36","author":"Palhares","year":"2018","journal-title":"Rev Paul Pediatr."},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0057","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0058","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.93.1.54","article-title":"Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults","volume":"93","author":"Bao","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0059","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mpd.2000.105141","article-title":"Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective","volume":"136","author":"Fagot-Campagna","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/0378-6323.198445","article-title":"A study of the association of acanthosis nigricans with subclinical atherosclerosis","volume":"83","author":"Guevara-Guti\u00e9rrez","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0061","first-page":"290","article-title":"Acanthosis nigricans in obese Chinese children","volume":"20","author":"Ng","year":"2014","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0062","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2004.07.050","article-title":"Plasma leptin and prognosis in patients with established coronary atherosclerosis","volume":"44","author":"Wolk","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0063","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1651-2227.2006.tb02202.x","article-title":"Genetic factors and clinical significance of acanthosis nigricans in obese Japanese children and adolescents","volume":"95","author":"Miura","year":"2006","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0064","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1111\/ijd.12340","article-title":"Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease","volume":"53","author":"Atwa","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1370\/afm.678","article-title":"Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices","volume":"5","author":"Kong","year":"2007","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0066","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report","volume":"118","author":"Akdis","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0067","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0068","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0069","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0070","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2007.08.067","article-title":"Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data","volume":"120","author":"Baurecht","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0071","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0072","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0073","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jaci.2009.05.020","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum","volume":"124","author":"Beck","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0074","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/acel.12120","article-title":"Effects of Caenorhabditis elegans sgk-1 mutations on lifespan, stress resistance, and DAF-16\/FoxO regulation","volume":"12","author":"Chen","year":"2013","journal-title":"Aging cell"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.07.058","article-title":"The role of Malassezia in atopic dermatitis affecting the head and neck of adults","volume":"60","author":"Darabi","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0076","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2741\/4225","article-title":"Skin barrier in atopic dermatitis","volume":"19","author":"Kezic","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0077","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1194\/jlr.P030338","article-title":"Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients","volume":"53","author":"Janssens","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0078","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2133.2009.09142.x","article-title":"Increased stratum corneum serine protease activity in acute eczematous atopic skin","volume":"161","author":"Voegeli","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0079","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri2735","article-title":"How are T(H)2-type immune responses initiated and amplified?","volume":"10","author":"Paul","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaci.2012.01.062","article-title":"An update on the role of human dendritic cells in patients with atopic dermatitis","volume":"129","author":"Novak","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0081","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: A\u00a0systematic review and meta-analysis of population-based studies","volume":"143","author":"Ascott","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0082","doi-asserted-by":"crossref","first-page":"k1786","DOI":"10.1136\/bmj.k1786","article-title":"Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study","volume":"361","author":"Silverwood","year":"2018","journal-title":"Bmj"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0083","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"Silverberg","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0084","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/bjd.16215","article-title":"The association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis","volume":"178","author":"Thyssen","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0085","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/bjd.15727","article-title":"Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project","volume":"177","author":"Drucker","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0086","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jaad.2019.08.039","article-title":"Atopic dermatitis and risk of atrial fibrillation or flutter: a 35-year follow-up study","volume":"83","author":"Schmidt","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0087","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mcna.2019.08.009","article-title":"Atopic dermatitis in adults","volume":"104","author":"Silverberg","year":"2020","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0088","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.smrv.2010.01.004","article-title":"Eczema and sleep and its relationship to daytime functioning in children","volume":"14","author":"Camfferman","year":"2010","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0089","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mai.2003.174","article-title":"Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure","volume":"111","author":"Bender","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/sleep\/33.2.177","article-title":"Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort","volume":"33","author":"Chien","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0091","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/ATVBAHA.115.305452","article-title":"Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis","volume":"35","author":"Tattersall","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0092","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamadermatol.2014.3059","article-title":"Central obesity and high blood pressure in pediatric patients with atopic dermatitis","volume":"151","author":"Silverberg","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0093","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2011.10694.x","article-title":"Association between atopic dermatitis and obesity in adulthood","volume":"166","author":"Silverberg","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0094","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2014.12.013","article-title":"Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis","volume":"72","author":"Zhang","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2016.03.063","article-title":"Associations of physical activity and sedentary behavior with atopic disease in United States children","volume":"174","author":"Strom","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0096","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jaci.2019.01.008","article-title":"Atopic dermatitis and cardiovascular disease: What are the clinical implications?","volume":"143","author":"Drucker","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0097","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0098","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0099","first-page":"72","article-title":"Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis","volume":"99","author":"Kridin","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0100","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1365-2133.2009.09350.x","article-title":"A population-based study of acute medical conditions associated with bullous pemphigoid","volume":"161","author":"Langan","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0101","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/jdv.14312","article-title":"Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls","volume":"31","author":"Sim","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0102","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0103","first-page":"11","article-title":"Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity","volume":"12","author":"D'Auria","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0104","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2133.2008.08880.x","article-title":"Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications","volume":"160","author":"Marzano","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2249.2012.04674.x","article-title":"Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease","volume":"171","author":"Marzano","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.15420\/ecr.2017:18:1","article-title":"Inflammation revisited: atherosclerosis in the post-CANTOS era","volume":"12","author":"Koenig","year":"2017","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0107","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0108","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0109","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0110","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaad.2020.01.032","article-title":"Association between bullous pemphigoid and ischemic heart diseases: a systematic review and meta-analysis","volume":"83","author":"Lai","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0111","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yexcr.2009.11.010","article-title":"BPAG1 isoform-b: complex distribution pattern in striated and heart muscle and association with plectin and alpha-actinin","volume":"316","author":"Steiner-Champliaud","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0112","doi-asserted-by":"crossref","first-page":"e9465","DOI":"10.1371\/journal.pone.0009465","article-title":"Hearts of dystonia musculorum mice display normal morphological and histological features but show signs of cardiac stress","volume":"5","author":"Boyer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0738-081X(98)00008-X","article-title":"Drug-induced pemphigoid: bullous and cicatricial","volume":"16","author":"Vassileva","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0114","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cpcardiol.2021.100799_bib0115","doi-asserted-by":"crossref","first-page":"adv00224","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden","year":"2020","journal-title":"Acta Derm Venereol"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:57:47Z","timestamp":1758938267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0146280621000141"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100799","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Systemic Inflammatory Skin Disease as a Risk Factor for Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100799"}}